RMHIOTCPharmaceutical PreparationsFiscal year ends September 30

Retrieve Medical Holdings, Inc.

Financials through Q1 FY2023, quarter ended Dec 31, 2022Last filing: 10-Q on Feb 9, 2023

$0.85+0.01 (+1.78%)

Close on Oct 19, 2026

Market cap: –
P/E (TTM): –
Dividend yield: –

Retrieve Medical Holdings, Inc. balance sheet

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2022 2022-09-30	FY 2021 2021-09-30	FY 2020 2020-09-30	FY 2019 2019-09-30	FY 2018 2018-09-30	FY 2017 2017-09-30	FY 2016 2016-09-30	FY 2015 2015-09-30	FY 2014 2014-09-30	FY 2013 2013-09-30	FY 2012 2012-09-30	FY 2011 2011-09-30	FY 2010 2010-09-30	FY 2009 2009-09-30	FY 2008 2008-09-30
Cash & Equivalents	0.13	0.26	0.00	0.00	0.00	0.00	0.00	0.20	0.45	0.00	0.00	0.00	0.02	0.01	–
Cash & Short-Term Investments	0.13	0.26	0.00	0.00	0.00	0.00	0.00	0.20	0.45	0.00	0.00	0.00	0.02	0.01	–
Prepaid Expenses & Other	0.00	–	–	–	–	–	0	–	–	–	–	0.00	0.00	–	–
Total Current Assets	–	–	0.00	0.00	0.00	0.00	0.00	0.26	0.46	0.00	0.01	–	–	–	–
Intangible Assets	–	–	–	–	–	0.04	0.04	0.02	–	–	–	–	–	–	–
Deferred Tax Assets	–	–	–	–	–	0.38	0.40	–	–	–	–	–	–	–	–
Total Assets	0.13	0.26	0.00	0.00	0.00	0.00	0.00	0.28	0.49	0.00	0.01	0.01	0.02	–	–
Accounts Payable	0.22	0.21	0.16	0.16	0.15	0.16	0.08	–	–	–	–	0.01	0.01	–	–
Accrued Expenses	0.12	0.04	0.02	0.02	0.01	0.01	0.01	–	–	–	–	–	–	–	–
Short-Term Debt	–	–	–	–	–	–	–	–	0.60	–	–	–	–	–	–
Current Debt	–	–	–	–	–	–	–	–	0.60	–	–	–	–	–	–
Total Current Liabilities	–	–	0.25	0.24	0.22	0.20	0.14	0.29	0.05	0.04	0.04	–	–	–	–
Total Liabilities	0.62	0.59	0.25	0.24	0.22	0.20	0.14	0.29	0.05	0.04	0.04	0.01	0.01	–	–
Total Debt	–	–	–	–	–	–	–	–	0.60	–	–	–	–	–	–
Preferred Stock	–	–	–	–	–	–	0	0	–	–	–	–	–	–	–
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.03	0.02	0.02	0.00	–	–
Additional Paid-In Capital	4.86	4.86	4.86	4.86	4.86	4.86	4.86	6.15	4.29	0.03	0.04	0.04	0.06	–	–
Retained Earnings	-5.35	-5.19	-5.11	-5.10	-5.08	-5.06	-5.00	-6.17	-3.86	-0.10	-0.09	–	–	–	–
Shareholders' Equity	-0.49	-0.33	-0.25	-0.24	-0.22	-0.19	-0.14	-0.01	0.44	-0.04	0.03	-0.01	0.01	0.01	0.01
Total Equity	-0.49	-0.33	-0.25	-0.24	-0.22	-0.19	-0.14	-0.01	0.44	-0.04	-0.03	-0.01	0.01	-0.01	0.01
Total Liabilities & Equity	0.13	0.26	0.00	0.00	0.00	0.00	0.00	0.28	0.49	0.00	0.01	0.01	0.02	–	–
Shares Outstanding(shares)	78	78	78	78	78	78	78	78	78	331	331	331	331	–	–
Allowance for Credit Losses	–	–	–	–	–	–	–	–	–	0.03	0.02	–	–	–	–
Deposits	–	–	–	–	–	–	–	0.00	0.00	–	–	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Dec 31, 2022

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2022: 40.4%

Financial strength

Current ratio: –
Debt to equity: –
Debt to assets: –
Cash to current liabilities: –

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –